Neuroprotection in Parkinson's disease: and now for something completely different?

被引：19

作者：

Lang, Anthony E. ^{[1
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

来源：

LANCET NEUROLOGY | 2006年 / 5卷 / 12期

关键词：

D O I：

10.1016/S1474-4422(06)70605-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：990 / 991

页数：2

共 16 条

[1]

[Anonymous], 2006, NEUROLOGY, DOI DOI 10.1212/01.WNL.0000234884.42413.BC

[2]

Fahn S, 2004, NEW ENGL J MED, V351, P2498

[3] Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial [J].

Holloway, R ;

Shoulson, I ;

Kieburtz, K ;

McDermott, M ;

Tariot, P ;

Kamp, C ;

Day, D ;

Shinaman, A ;

Fahn, S ;

Lang, A ;

Marek, K ;

Seibyl, J ;

Weiner, W ;

Welsh, M ;

Pahwa, R ;

Coe, S ;

Barclay, L ;

Sutherland, L ;

Hildebrand, K ;

Hubble, J ;

Weeks, C ;

LeWitt, P ;

Miyasaki, J ;

Duff, J ;

Sime, E ;

Suchowersky, O ;

Stacy, M ;

Kurth, M ;

Brewer, M ;

Harrigan, M ;

Russell, DS ;

Fussell, B ;

Ford, B ;

Dillon, S ;

Hammerstad, J ;

Stone, C ;

Riley, D ;

Rainey, P ;

Standaert, D ;

Tennis, M ;

Wooten, F ;

Rost-Ruffner, E ;

Factor, S ;

Brown, D ;

Jankovic, J ;

Atassi, F ;

Kurlan, R ;

Gardiner, I ;

Panisset, M ;

Amyot, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15) :1931-1938

[4]

KIEBUTZ K, 2006, NEUROLOGY S4, V66, pSS50

[5] TCH346 as a neuroprotective drug in Parkinson"s disease: a double-blind, randomised, controlled trial [J].

Olanow, C. Warren ;

Schapira, Anthony H. V. ;

LeWitt, Peter A. ;

Kieburtz, Karl ;

Sauer, Dirk ;

Olivieri, Gianfranco ;

Pohlmann, Harald ;

Hubble, Jean .

LANCET NEUROLOGY, 2006, 5 (12) :1013-1020

[6] THE EFFECT OF DEPRENYL AND LEVODOPA ON THE PROGRESSION OF PARKINSONS-DISEASE [J].

OLANOW, CW ;

HAUSER, RA ;

GAUGER, L ;

MALAPIRA, T ;

KOLLER, W ;

HUBBLE, J ;

BUSHENBARK, K ;

LILIENFELD, D ;

ESTERLITZ, J .

ANNALS OF NEUROLOGY, 1995, 38 (05) :771-777

[7] Selegiline slows the progression of the symptoms of Parkinson disease [J].

Pålhagen, S ;

Heinonen, E ;

Hägglund, J ;

Kaugesaar, T ;

Mäki-Ikola, O ;

Palm, R .

NEUROLOGY, 2006, 66 (08) :1200-1206

[8]

Rascol O, 2002, MOVEMENT DISORD, V17, pS39

[9]

Ravina B, 2006, NEUROLOGY, V66, P664

[10] Neuroprotective agents for clinical trials in Parkinson's disease - A systematic assessment [J].

Ravina, BM ;

Fagan, SC ;

Hart, RG ;

Hovinga, CA ;

Murphy, DD ;

Dawson, TM ;

Marler, JR .

NEUROLOGY, 2003, 60 (08) :1234-1240

← 1 2 →